ArticlePDF Available

Abstract and Figures

Normobaric oxygen (NBO) and hyperbaric oxygen (HBO) are emerging as a possible co-treatment of acute ischemic stroke. Both have been shown to reduce infarct volume, to improve neurologic outcome, to promote endogenous tissue plasminogen activator-induced thrombolysis and cerebral blood flow, and to improve tissue oxygenation through oxygen diffusion in the ischemic areas, thereby questioning the interest of HBO compared to NBO. In the present study, in order to investigate and compare the oxygen diffusion effects of NBO and HBO on acute ischemic stroke independently of their effects at the vascular level, we used acute brain slices exposed to oxygen and glucose deprivation, an ex vivo model of brain ischemia that allows investigating the acute effects of NBO (partial pressure of oxygen (pO 2 ) = 1 atmospheres absolute (ATA) = 0.1 MPa) and HBO (pO 2 = 2.5 ATA = 0.25 MPa) through tissue oxygenation on ischemia-induced cell injury as measured by the release of lactate dehydrogenase. We found that HBO, but not NBO, reduced oxygen and glucose deprivation-induced cell injury, indicating that passive tissue oxygenation (i.e. without vascular support) of the brain parenchyma requires oxygen partial pressure higher than 1 ATA.
Content may be subject to copyright.
© 2016 Medical Gas Research | Published by Wolters Kluwer - Medknow 169
IntroductIon
Hyperbaric oxygen (HBO) improves outcome in experimen-
tal cerebral ischemia and is therefore emerging as a possible
co-treatment for acute ischemic stroke in addition of tissue
plasminogen activator (tPA), whose recombinant form is
considered the best approved treatment for acute brain
ischemia to date (Peplow, 2015). Thus, despite controversial
results that have shown that HBO enlarges ischemic brain
damage by blocking autophagy (Lu et al., 2014) and further
SHORT COMMUNICATION
produces vasoconstriction (Stirban et al., 2009), a condi-
tion thought to be deleterious in stroke disease, numerous
investigations have reported benecial effects of HBO on
infarct size and neurological decits (Veltkamp et al., 2000,
2005; Eschenfelder et al., 2008; Yang et al., 2010; Xu et al.,
2016). Although the mechanisms of action of HBO are not
well established and are still lively under discussion, HBO
has been shown to induce neurogenesis (Lee et al., 2013), to
improve the decrease in tissue oxygenation induced by isch-
Effects of normobaric versus hyperbaric oxygen on cell injury
induced by oxygen and glucose deprivation in acute brain slices
Laurent Chazalviel1, Jean-Eric Blatteau2, Nicolas Vallée3, Jean-Jacques Risso3, Stéphane Besnard4,
Jacques H. Abraini3, 5, 6, *
1 Normandie Université, UNICAEN, CNRS, UMR 6301 ISTCT, Equipe Cervoxy, Caen, France
2 Hôpital d’Instruction des Armées (HIA) Sainte-Anne, Service de Médecine Hyperbare et Expertise Plongée (SMHEP), Toulon, France
3 Institut de Recherche Biomédicale des Armées (IRBA), Equipe Résidente de Recherche Subaquatique Opérationnelle (ERRSO),
Toulon, France
4 Normandie Université, UNICAEN, INSERM, UMR 1075, Caen, France
5 Normandie Université, UNICAEN, Faculté de Médecine, France
6 Université Laval, Département d’Anesthésiologie, Québec, Canada
*Correspondence to: Jacques H. Abraini, jh.abraini@gmail.com.
orcid: 0000-0002-6435-9819
Normobaric oxygen (NBO) and hyperbaric oxygen (HBO) are emerging as a possible co-treatment of acute ischemic stroke. Both have
been shown to reduce infarct volume, to improve neurologic outcome, to promote endogenous tissue plasminogen activator-induced
thrombolysis and cerebral blood ow, and to improve tissue oxygenation through oxygen diffusion in the ischemic areas, thereby ques-
tioning the interest of HBO compared to NBO. In the present study, in order to investigate and compare the oxygen diffusion effects
of NBO and HBO on acute ischemic stroke independently of their effects at the vascular level, we used acute brain slices exposed to
oxygen and glucose deprivation, an ex vivo model of brain ischemia that allows investigating the acute effects of NBO (partial pressure
of oxygen (pO2) = 1 atmospheres absolute (ATA) = 0.1 MPa) and HBO (pO2 = 2.5 ATA = 0.25 MPa) through tissue oxygenation on
ischemia-induced cell injury as measured by the release of lactate dehydrogenase. We found that HBO, but not NBO, reduced oxygen
and glucose deprivation-induced cell injury, indicating that passive tissue oxygenation (i.e. without vascular support) of the brain
parenchyma requires oxygen partial pressure higher than 1 ATA.
Key words: hyperbaric oxygen; normobaric oxygen; oxygen diffusion; lactate dehydogenase; cell injury; brain slices; oxygen and
glucose deprivation; brain ischemia
doi: 10.4103/2045-9912.191364
How to cite this article: Chazalviel L, Blatteau JE, Vallée N, Risso JJ, Besnard S, Abraini JH
(2016) Effects of normobaric versus
hyperbaric oxygen on cell injury induced by oxygen and glucose deprivation in acute brain slices. Med Gas Res 6(3):169-173.
Abstract
[Downloaded free from http://www.medgasres.com on Monday, March 20, 2023, IP: 89.184.199.114]
Med Gas Res ¦ September ¦ Volume 6 ¦ Issue 3
170
Chazalviel L, et al. / Med Gas Res www.medgasres.com
emia (Sun et al., 2008), to promote thrombolysis through
activation of endogenous tPA (Chazalviel et al., 2016b), and
to reduce the decrease in regional glucose metabolism (Lou
et al., 2007). Likewise, interestingly, normobaric oxygen
(NBO) has also been shown to reduce infarct size (Singhal
et al., 2002; Henninger et al., 2007; David et al., 2012), to
induce neurogenesis (Wagenfuhr et al., 2016), to promote
endogenous tPA-induced thrombolysis (David et al., 2012) ,
to increase cerebral blow ow and to improve the decrease
in tissue oxygenation induced by ischemia (Liu et al., 2004,
2006; Shin et al., 2007; Baskerville et al., 2011), thereby
questioning the interest of HBO compared to NBO in the
treatment of acute brain ischemia.
Therefore, in the present study, we investigated and
compared the effects of a post-insult treatment with NBO
(partial pressure of oxygen (pO2) = 1 atmospheres absolute
(ATA) = 0.1 MPa) or HBO (pO2 = 2.5 ATA = 0.25 MPa)
on the release of lactate dehydrogenase (LDH) – used as
a marker of cell injury – in acute brain slices exposed to
oxygen and glucose deprivation (OGD), an ex vivo model
of brain ischemia.
MaterIals and Methods
Materials
Brain slices were drawn from male adult Sprague-Dawley
rats (n = 15; Janvier, Le Genest Saint-Isle, France) weighing
250–280 g according to an animal use procedure approved
by the University of Caen ethics committee in accordance
with the Declaration of Helsinki and the framework of the
French legislation for the use of animals in biomedical
experimentation.
Rats were sacriced by decapitation under anesthesia,
and the brains were carefully removed and placed in ice-
cold freshly prepared articial cerebrospinal uid (aCSF)
containing 120 mM NaCl, 2 mM KCl, 2 mM CaCl2, 26
mM NaHCO3, 1.19 mM MgSO4, 1.18 mM KH2PO4, 11
mM D-glucose, and 30 mM HEPES (pH = 7.4). Coronal
brain slices of 400-μm thickness including the striatum
(anteriority: from −1.2 mm to +2 mm from bregma) were
cut using a tissue chopper (Mickie Laboratory Engineering
Co., Gomshall, Surrey, UK), and allowed to recover at room
temperature for 45 minutes.
Intervention and total LDH release analysis
After recovery at room temperature, brain slices were
incubated individually in a home made 16-vials versatile
normobaric-hyperbaric chamber (Blatteau et al., 2014)
that was placed in an oven at 36 ± 0.5°C. Temperature was
controlled using a temperature probe placed in an empty
vial. Each vial contained 1.3 mL of freshly prepared aCSF,
saturated, and continuously bubbled with 100% oxygen (25
mL/min per vial). After a 30-minute period of stabilization,
aCSF was renewed with oxygenated aCSF, and the slices
were then incubated for an additional 1-hour period to al-
low recording basal LDH levels. Whereas sham slices were
incubated for an additional 20-minute period in the same
conditions, those corresponding to the ischemic groups
were incubated in a glucose-free solution, saturated, and
continuously bubbled with 100% nitrogen (OGD slices).
After this 20-minute period of OGD, the medium was
replaced in all groups with freshly prepared aCSF, and the
slices were treated and continuously bubbled for a 3-hour
period with either normobaric medical air composed of
75% nitrogen and 25% oxygen (control slices) or with nor-
mobaric 100% oxygen (NBO-treated slices). HBO treated
slices were pressurized at a compression rate of 1 ATA/min
with 100% oxygen up to 2.5 ATA. After a 3-hour period at
2.5 ATA, during which increased oxygen level was provided
to the slices through oxygen diffusion and equilibrium be-
tween “air” and saline, decompression was performed at a
slow decompression rate of 0.1 ATA/min shown to induce
no cell injury (Baskerville et al., 2011; Blatteau et al., 2014).
To avoid multiple compression and decompression in the
HBO experiment, aCSF was not replaced and served as a
pool throughout the 3-hour period of treatment with medi-
cal air, NBO or HBO.
OGD-induced neuronal injury was quantied by the
amount of LDH released in the incubation solution samples.
LDH activity was measured using a spectrophotometer at
340 nm in 50 µL of incubation medium by following the
oxidation (decrease in absorbance) of 100 mL of β nico-
tinamide adenine dinucleotide (NADH) (3 mg in 10 mL
of PBS) in 20 µL of sodium pyruvate (6.25 mg in 10 mL
of PBS) using a microplate reader. OGD-induced LDH
efuxes were expressed as the amount of LDH measured
in the incubation solution and as a percentage of pre-OGD
control value. The number of animals and the number of
slices was respectively n = 4-6 and n = 24-32 per condition.
Statistical analysis
Data are expressed as the mean ± standard error of the mean,
and were analyzed using parametric statistics. Between-
group comparisons on total LDH release were performed
using parametric ANOVA. Following a significant F
value, post-hoc analysis was performed using the Tukey’s
honestly signicant difference method for samples of dif-
ferent size (online software: http://statistica.mooo.com/
OneWay_Anova_with_TukeyHSD). Level of signicance
was set up at P < 0.05.
results
Brain slices were exposed to experimental ischemia in the
[Downloaded free from http://www.medgasres.com on Monday, March 20, 2023, IP: 89.184.199.114]
Med Gas Res ¦ September ¦ Volume 6 ¦ Issue 3 171
Chazalviel L, et al. / Med Gas Res www.medgasres.com
with the same device in our laboratory in in vitro models
of thrombolysis (Abraini, 2013; Chazalviel et al., 2016b).
In addition, from a clinical perspective, this point is not
of major critical importance since such a procedure with
10% oxygen is not current therapeutic practice. Finally, the
cerebral slices’ vital activity was not measured. However,
we have previously shown using pharmacological and
neurochemical approaches measuring carrier-mediated-
and KCl-evoked dopamine release that acute brain slices
exposed to similar control and OGD conditions that those
used in the present report remained functional (David et
al., 2008).
That said, both NBO and HBO have been shown to re-
duce infarct size (Veltkamp et al., 2000, 2005; Singhal et
al., 2002; Henninger et al., 2007; Eschenfelder et al., 2008;
Yang et al., 2010; David et al., 2012; Xu et al., 2016), to
promote endogenous tPA-induced thrombolysis (David et
al., 2012; Chazalviel et al., 2016b), to improve ischemia-
induced decrease in tissue oxygenation (Liu et al., 2004,
2006; Shin et al., 2007; Sun et al., 2008; Baskerville et
al., 2011), and to induce neurogenesis (Lee et al., 2013;
Wagenfuhr et al., 2016), thereby questioning the interest
of HBO compared to NBO in stroke. In the present study,
to investigate this question, we compare the oxygen diffu-
sion effects of NBO and HBO in acute brain slices exposed
to OGD, an ex vivo model of brain ischemia that allows
investigating the acute effects of NBO and HBO on tissue
(parenchyma) oxygenation independently of their facilitat-
ing action on cerebral blood ow and thrombolysis at the
vascular level and of their long term effects on neurogenesis.
We found that HBO, but not NBO, reduced OGD-induced
cell injury, thereby indicating that to be fully efcient
oxygen diffusion-induced tissue oxygenation of the brain
parenchyma requires oxygen partial pressure higher than 1
ATA. Consistent with our ndings of a lack of signicant
effect of NBO through passive-mediated oxygen transport is
the fact that both NBO and HBO, administered 1 hour before
thrombolysis, have been shown to reduce infarct size in rats
subjected to transient thromboembolic brain ischemia, but
that only HBO but not NBO has been further demonstrated
to decrease infarct volume in permanent thromboembolic
middle cerebral artery occlusion-induced ischemia (Sun et
al., 2010). The apparent discrepancy between our nding
of a lack of effect of NBO at reducing cell injury in brain
slices exposed to OGD and the benecial effect of NBO
at reducing infarct size in rats subjected to transient brain
ischemia (Sun et al., 2010) could be due to the fact that this
latter study was performed in vivo, conditions in which mi-
crovasculature could play a major role in oxygen transport
(Chazalviel et al., 2016a). Indeed, interestingly, as a possible
mechanism for the facilitating action of NBO on cerebral
form of OGD to determine the effect of NBO and HBO on
OGD-induced neuronal injury as assessed by the release of
LDH. Figure 1 illustrates the effects of a 3-hour treatment
with of NBO (pO2 = 1 ATA) or HBO (pO2 = 2.5 ATA) on
LDH release induced by OGD. Exposure to OGD led to an
increase in LDH release compared with sham slices (Tukey
HSD value = 0.0010053; P < 0.01). Post-insult treatment
with NBO showed no signicant effect on OGD-induced
LDH release compared to control slices treated with air
(Tukey HSD value = 0.8975409). In contrast, post-insult
treatment with HBO led to a signicant reduction in LDH
release compared to both control slices and NBO-treated
slices (Tukey HSD value = 0.0010053; P < 0.01).
dIscussIon
Before discussing our ndings, possible limitations in
study design should be examined. First, aCSF was used as
a pool for brain slices and was not replaced throughout the
experiment, conditions that could have lead to LDH decay
or accumulation. However, we used this protocol to avoid
multiple compression and decompression in the HBO ex-
periment, conditions that would have led to LDH release
induced by decompression stress (Blatteau et al., 2014,
2015) and therefore to experimental bias compared to the
control and NBO groups. Second, no hyperbaric experiment
was performed with 10% oxygen to investigate the possible
effect of pressure per se. However, support for an effect of
HBO rather than pressure per se is previous data performed
Figure 1: Exposure to oxygen and glucose deprivation (OGD) results in
an increase of lactate dehydrogenase (LDH) release compared to sham
(SHM) slices taken as a 100% value.
Note: Hyperbaric oxygen (HBO), but not normobaric oxygen (NBO), reduces
LDH release in brain slices exposed to OGD compared to control air-treated
slices (AIR). #P < 0.01, vs. sham slices; *P < 0.01, vs. control air-treated slices.
[Downloaded free from http://www.medgasres.com on Monday, March 20, 2023, IP: 89.184.199.114]
Med Gas Res ¦ September ¦ Volume 6 ¦ Issue 3
172
Chazalviel L, et al. / Med Gas Res www.medgasres.com
highlights one of the mechanisms by which HBO, in ad-
dition of other multiple processes, seems to be efcient at
reducing brain damage in acute stroke models.
Author contributions
LC performed the experiments. JEB, NV, JJR, SB, and
JHA designed the experiments, analyzed data, and wrote
the manuscript.
Conflicts of interest
The authors declared no competing interest.
references
Abraini JH (2013) Oxygen for the ischemic organ: much more than
an oxygen provider. Undersea Hyperb Med 40:211-212.
Aronowski J, Strong R, Grotta JC (1997) Reperfusion injury: dem-
onstration of brain damage produced by reperfusion after transient
focal ischemia in rats. J Cereb Blood Flow Metab 17:1048-1056.
Austin V, Crack PJ, Bozinovski S, Miller AA, Vlahos R (2016)
COPD and stroke: are systemic inammation and oxidative stress
the missing links? Clin Sci (Lond) 130:1039-1050.
Baskerville TA, Deuchar GA, McCabe C, Robertson CA, Holmes
WM, Santosh C, Macrae IM (2011) Inuence of 100% and
40% oxygen on penumbral blood ow, oxygen level, and T2*-
weighted MRI in a rat stroke model. J Cereb Blood Flow Metab
31:1799-1806.
Blatteau JE, David HN, Vallee N, Meckler C, Demaistre S, Risso JJ,
Abraini JH (2014) Cost-efcient method and device for the study
of stationary tissular gas bubble formation in the mechanisms of
decompression sickness. J Neurosci Methods 236:40-43.
Blatteau JE, David HN, Vallée N, Demaistre S, Lambrechts K, Risso
JJ, Abraini JH (2015) Xenon blocks neuronal injury induced by
tissular gas bubble formation in decompression sickness. Sci Rep
5:15093.
Chamorro A, Dirnagl U, Urra X, Planas AM (2016) Neuroprotection
in acute stroke: targeting excitotoxicity, oxidative and nitrosative
stress, and inammation. Lancet Neurol 15:869-881.
Chazalviel L, David HN, Haelewyn B, Blatteau JE, Vallee N, Risso
JJ, Besnard S, Abraini JH (2016a) The underestimated effect of
normobaric hyperoxia on cerebral blood ow and its relationship
to neuroprotection. Brain doi: 10.1093/brain/aww178.
Chazalviel L, Haelewyn B, Degoulet M, Blatteau JE, Vallée N, Risso
JJ, Besnard S, Abraini JH (2016b) Hyperbaric oxygen increases
tissue-plasminogen activator-induced thrombolysis in vitro, and
reduces ischemic brain damage and edema in rats subjected to
thromboembolic brain ischemia. Med Gas Res 6:64-69.
David HN, Haelewyn B, Degoulet M, Colomb DG Jr, Risso JJ,
Abraini JH (2012) Prothrombolytic action of normobaric oxygen
given alone or in combination with recombinant tissue-plasmin-
ogen activator in a rat model of thromboembolic stroke. J Appl
Physiol (1985) 112:2068-2076.
David HN, Haelewyn B, Rouillon C, Lecoq M, Chazalviel L, Apiou
G, Risso JJ, Lemaire M, Abraini JH (2008) Neuroprotective ef-
fects of xenon: a therapeutic window of opportunity in rats sub-
jected to transient cerebral ischemia. FASEB J 22:1275-1286.
blood ow, NBO has been demonstrated to promote endog-
enous tPA-induced thrombolysis (David et al., 2012), effect
that could maintain the microvasculature of the ischemic
areas opened despite ischemia-induced thrombin generation
and blood platelet aggregation (Chazalviel et al., 2016a).
Alternatively and in contrast with these benecial ef-
fects, there is a growing number of evidence highlighting
potential harmful effect of hyperoxia in acute ischemic
events such as stroke and cardiac arrest (Austin et al., 2016;
Sepehrvand and Ezekowitz, 2016). These effects are sug-
gested to be gauged by the increased production of reactive
oxygen species and the related oxidative stress resulting
from hyperoxia-induced vasoconstriction in the cerebral,
coronary, and systemic vasculature. As a consequence,
targeting oxidative stress and inammation in addition of
excitotoxicity has been suggested as a promising strategy
(Chamorro et al., 2016). However, providing hyperoxia
through NBO or HBO during ischemia (Veltkamp et al.,
2000, 2005; Singhal et al., 2002; Henninger et al., 2007;
Eschenfelder et al., 2008; Yang et al., 2010; David et al.,
2012; Xu et al., 2016), but not during reperfusion (Mickel
et al., 1987; Aronowski et al., 1997; Haelewyn et al., 2011),
has been repeatedly shown to be a safe and effective therapy
in animal models of acute brain ischemia. Consistent with
these data, recent ndings have shown that very brief
exposure to HBO of 5-minute duration reduced ischemic
brain damage probably by promoting thrombolysis, while
in contrast longer exposure to HBO of 25-minute duration
increases brain damage (Chazalviel et al., 2016b). There-
fore, it is likely that hyperoxia could have dual effects:
on one hand, inducing benets when administered during
ischemia by promoting thrombolysis (David et al., 2012)
thereby avoiding blood platelet aggregation and coagulation
(Chazalviel et al., 2016a) and increasing oxygen tension in
the ischemic penumbra (Liu et al., 2004, 2006; Shin et al.,
2007; Sun et al., 2008; Baskerville et al., 2011) through
vascular oxygen transport (Shin et al., 2007; Baskerville
et al., 2011; Chazalviel et al., 2016a) and so far HBO is
concerned passive-mediated oxygen transport as shown
in the present study, and on the other hand by inducing
adverse responses through oxidative stress and free radical
formation that would overturn the benets of hyperoxia and
particularly HBO when administered in a prolonged fashion
after ischemia (Mickel et al., 1987; Aronowski et al., 1997;
Austin et al., 2016; Chamorro et al., 2016; Sepehrvand and
Ezekowitz, 2016).
In conclusion, this study provides evidence that HBO,
but not NBO, can induce passive-mediated oxygen diffusion
(i.e. without vascular support) of the brain parenchyma. This
indicates that tissue oxygenation through oxygen diffusion
requires oxygen partial pressures higher than 1 ATA. This
[Downloaded free from http://www.medgasres.com on Monday, March 20, 2023, IP: 89.184.199.114]
Med Gas Res ¦ September ¦ Volume 6 ¦ Issue 3 173
Chazalviel L, et al. / Med Gas Res www.medgasres.com
Eschenfelder CC, Krug R, Yuso AF, Meyne JK, Herdegen T, Koch
A, Zhao Y, Carl UM, Deuschl G (2008) Neuroprotection by oxy-
gen in acute transient focal cerebral ischemia is dose dependent
and shows superiority of hyperbaric oxygenation. Cerebrovasc
Dis 25:193-201.
Haelewyn B, Chazalviel L, Nicole O, Lecocq M, Risso JJ, Abraini
JH (2011) Moderately delayed post-insult treatment with normo-
baric hyperoxia reduces excitotoxin-induced neuronal degenera-
tion but increases ischemia-induced brain damage. Med Gas Res
1:2.
Henninger N, Bouley J, Nelligan JM, Sicard KM, Fisher M (2007)
Normobaric hyperoxia delays perfusion/diffusion mismatch evo-
lution, reduces infarct volume, and differentially affects neuronal
cell death pathways after suture middle cerebral artery occlusion
in rats. J Cereb Blood Flow Metab 27:1632-1642.
Lee YS, Chio CC, Chang CP, Wang LC, Chiang PM, Niu KC, Tsai
KJ (2013) Long course hyperbaric oxygen stimulates neurogen-
esis and attenuates inammation after ischemic stroke. Mediators
Inamm 2013:512978.
Liu S, Shi H, Liu W, Furuichi T, Timmins GS, Liu KJ (2004) Inter-
stitial pO2 in ischemic penumbra and core are differentially af-
fected following transient focal cerebral ischemia in rats. J Cereb
Blood Flow Metab 24:343-349.
Liu S, Liu W, Ding W, Miyake M, Rosenberg GA, Liu KJ (2006)
Electron paramagnetic resonance-guided normobaric hyperoxia
treatment protects the brain by maintaining penumbral oxygen-
ation in a rat model of transient focal cerebral ischemia. J Cereb
Blood Flow Metab 26:1274-1284.
Lou M, Zhang H, Wang J, Wen SQ, Tang ZQ, Chen YZ, Yan WQ,
Ding MP (2007) Hyperbaric oxygen treatment attenuated the de-
crease in regional glucose metabolism of rats subjected to focal
cerebral ischemia: a high resolution positron emission tomogra-
phy study. Neuroscience 146:555-561.
Lu Y, Kang J, Bai Y, Zhang Y, Li H, Yang X, Xiang X, Wang X,
Huang Y, Su J, Chen Y, Li B, Sun L (2014) Hyperbaric oxygen
enlarges the area of brain damage in MCAO rats by blocking au-
tophagy via ERK1/2 activation. Eur J Pharmacol 728:93-99.
Mickel HS, Vaishnav YN, Kempski O, von Lubitz D, Weiss JF,
Feuerstein G (1987) Breathing 100% oxygen after global brain
ischemia in Mongolian Gerbils results in increased lipid peroxi-
dation and increased mortality. Stroke 18:426-430.
Peplow PV (2015) Neuroimmunomodulatory effects of transcranial
laser therapy combined with intravenous tPA administration for
acute cerebral ischemic injury. Neural Regen Res 10:1186-1190.
Sepehrvand N, Ezekowitz JA (2016) Oxygen therapy in patients
with acute heart failure: friend or foe? JACC Heart Fail doi:
10.1016/j.jchf.2016.03.026.
Shin HK, Dunn AK, Jones PB, Boas DA, Lo EH, Moskowitz MA,
Ayata C (2007) Normobaric hyperoxia improves cerebral blood
ow and oxygenation, and inhibits peri-infarct depolarizations in
experimental focal ischaemia. Brain 130:1631-1642.
Singhal AB, Dijkhuizen RM, Rosen BR, Lo EH (2002) Normobaric
hyperoxia reduces MRI diffusion abnormalities and infarct size in
experimental stroke. Neurology 58:945-952.
Stirban A, Lentrodt S, Nandrean S, Pop A, Tschoepe D, Scherbaum
WA (2009) Functional changes in microcirculation during hy-
perbaric and normobaric oxygen therapy. Undersea Hyperb Med
36:381-390.
Sun L, Marti HH, Veltkamp R (2008) Hyperbaric oxygen reduces
tissue hypoxia and hypoxia-inducible factor-1 alpha expression
in focal cerebral ischemia. Stroke 39:1000-1006.
Sun L, Zhou W, Mueller C, Sommer C, Heiland S, Bauer AT, Marti
HH, Veltkamp R (2010) Oxygen therapy reduces secondary hem-
orrhage after thrombolysis in thromboembolic cerebral ischemia.
J Cereb Blood Flow Metab 30:1651-1660.
Veltkamp R, Warner DS, Domoki F, Brinkhous AD, Toole JF, Busija
DW (2000) Hyperbaric oxygen decreases infarct size and behav-
ioral decit after transient focal cerebral ischemia in rats. Brain
Res 853:68-73.
Veltkamp R, Siebing DA, Sun L, Heiland S, Bieber K, Marti HH,
Nagel S, Schwab S, Schwaninger M (2005) Hyperbaric oxygen
reduces blood-brain barrier damage and edema after transient fo-
cal cerebral ischemia. Stroke 36:1679-1683.
Wagenfuhr L, Meyer AK, Marrone L, Storch A (2016) Oxygen ten-
sion within the neurogenic niche regulates dopaminergic neuro-
genesis in the developing midbrain. Stem Cells Dev 25:227-238.
Xu Y, Ji R, Wei R, Yin B, He F, Luo B (2016) The efcacy of hy-
perbaric oxygen therapy on middle cerebral artery occlusion in
animal studies: a meta-analysis. PLoS One 11:e0148324.
Yang ZJ, Xie Y, Bosco GM, Chen C, Camporesi EM (2010) Hy-
perbaric oxygenation alleviates MCAO-induced brain injury and
reduces hydroxyl radical formation and glutamate release. Eur J
Appl Physiol 108:513-522.
[Downloaded free from http://www.medgasres.com on Monday, March 20, 2023, IP: 89.184.199.114]
... Acute ischemic stroke is among the leading causes of death and long-term disability in elders [45,46]. Ischemia and hypoxia resulting from arterial occlusion or hypotension in patients lead to major damage to the brain with glucose deprivation, which causes endoplasmic ER stress and neuronal death [47][48][49]. Recent research suggested that neuronal ischemic injury increased cell cytoxicity and apoptosis, which occurred via the activation of IRE1-TRAF2 pathway and downstream kinases which further activated JNK and p38 MAPK [50][51][52]. ...
Article
Full-text available
The accumulation of misfolded or unfolded proteins in endoplasmic reticulum (ER) lumen results in activation of an adaptive stress process called the unfolded protein response (UPR). As the most conserved signaling branch of the UPR, Inositol-requiring enzyme 1 (IRE1) possesses both Ser/Thr kinase and RNase activities that operates as a major stress sensor, mediating both adaptive and pro-apoptotic pathways under ER stress. Over the last three decades, a mounting body of evidence has shown that IRE1 signaling dysfunction is involved in pathology of various neurological disorders. Targeting this pathway has emerged as a promising therapeutic strategy against these diseases. In this review, we provide a general overview about the expression and physiological function of IRE1 signaling and its pathophysiological roles in central nervous system diseases.
... Hyperbaric oxygen (HBO) therapy, treatment providing 100% oxygen at a pressure greater than that at sea level, can be considered as one of these methods. In this regard, studies documented that HBO have neuroprotective effects against traumatic brain and spinal cord injury [11,12], ischemic brain and spinal cord injury [13,14], neurodegenerative disorders [15,16], oxidative damage in neuronal culture [17], and neuropathic pain [18]. ...
Article
Full-text available
Background: Recent studies shows that hyperbaric oxygen (HBO) therapy exerts some protective effects against neural injuries. The purpose of this study was to determine the neuroprotective effects of HBO following sciatic nerve transection (SNT). Methods: Rats were randomly divided into five groups (n = 14 per group): Sham-operated (SH) group, SH + HBO group, SNT group, and SNT + pre- and SNT + post-HBO groups (100% oxygen at 2.0 atm absolute, 60 min/day for five consecutive days beginning on 1 day before and immediately after nerve transaction, respectively). Spinal cord segments of the sciatic nerve and related dorsal root ganglions (DRGs) were removed 4 weeks after nerve transection for biochemical assessment of malodialdehyde (MDA) levels in spinal cord, biochemical assessment of superoxide dismutase (SOD) and catalse (CAT) activities in spinal cord, immunohistochemistry of caspase-3, cyclooxigenase-2 (COX-2), S100beta (S100ß), and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) in spinal cord and DRG. Results: The results revealed that MDA levels were significantly decreased in the SNT + pre-HBO group, while SOD and CAT activities were significantly increased in SNT + pre- and SNT + post-HBO treated rats. Attenuated caspase-3 and COX-2 expression, and TUNEL reaction could be significantly detected in the HBO-treated rats after nerve transection. Also, HBO significantly increased S100ß expression. Conclusions: Based on these results, we can conclude that pre- and post-HBO therapy had neuroprotective effects against sciatic nerve transection-induced degeneration.
... HBOT is still a promising strategy to treat acute cerebral ischemic stroke. Future directions include experiments on different models of ischemic cerebrovascular diseases, 69 cocktail treatment 14,70 with NBOT, 71 well designed clinical trials and more mechanism studies. ...
Article
Full-text available
Intravenous recombinant tissue-type plasminogen activator (r-tPA, alteplase) remains the recommended therapy for acute ischemic stroke. However, several factors are limiting its practical use. It makes it urgent for us to search more efficient strategies that can save the ischemic neurons, and safely extend the time window, while in the mean time reducing the detrimental effects for stroke thrombolysis. Hyperbaric oxygen therapy (HBOT) is considered to be potentially neuroprotective. Co-administration of r-tPA and HBOT has already been proved to be effective, safe and feasible in myocardial infarction. In this article, we would like to review whether HBOT has any beneficial effects on r-tPA thrombolysis. If there is, what is the underlying possible mechanisms and how to optimize for maximal effects?
... However, contrary to this straightforward reasoning, and to hyperbaric oxygen therapy, NBO has been shown to fail reducing cell injury in acute brain slices exposed to oxygen and glucose deprivation (Chazalviel et al., 2016). Also, while NBO and hyperbaric oxygen therapy have both been reported to reduce infarct size in rats subjected to transient thromboembolic brain ischaemia when administered 1 h before tPA, it is noteworthy that only hyperbaric oxygen therapy has been shown to reduce infarct volume in similar conditions in rats subjected to permanent doi:10.1093/brain/aww178 ...
Article
Full-text available
The presence of a salvageable penumbra, a region of ischemic brain tissue with sufficient energy for short-term survival, has been widely agreed as the premise for thrombolytic therapy with tissue plasminogen activator (tPA), which remains the only United States Food and Drug Administration (FDA) approved treatment for acute ischemia stroke. However, the use of tPA has been profoundly constrained due to its narrow therapeutic time window and the increased risk of potentially deadly hemorrhagic transformation (HT). Blood brain barrier (BBB) damage within the thrombolytic time window is an indicator for tPA-induced HT and both normobaric hyperoxia (NBO) and hypothermia have been shown to protect the BBB from ischemia/reperfusion injury. Therefore, providing the O2 as soon as possible (NBO treatment), freezing the brain (hypothermia treatment) to slow down ischemia-induced BBB damage or their combined use may extend the time window for the treatment of tPA. In this review, we summarize the protective effects of NBO, hypothermia or their use combined with tPA on ischemia stroke, based on which, the combination of NBO and hypothermia may be an ideal early stroke treatment to preserve the ischemic penumbra. Given this, there is an urge for large randomized controlled trials to address the effect.
Article
Full-text available
Recent data have shown that normobaric oxygen (NBO) increases the catalytic and thrombolytic efficiency of recombinant tissue plasminogen activator (rtPA) in vitro, and is as efficient as rtPA at restoring cerebral blood flow in rats subjected to thromboembolic brain ischemia. Therefore, in the present study, we studied the effects of hyperbaric oxygen (HBO) (i) on rtPA-induced thrombolysis in vitro and (ii) in rats subjected to thromboembolic middle cerebral artery occlusion-induced brain ischemia. HBO increases rtPA-induced thrombolysis in vitro to a greater extent than NBO; in addition, HBO treatment of 5-minute duration, but not of 25-minute duration, reduces brain damage and edema in vivo. In line with the facilitating effect of NBO on cerebral blood flow, our findings suggest that 5-minute HBO could have provided neuroprotection by promoting thrombolysis. The lack of effect of HBO exposure of longer duration is discussed.
Article
Full-text available
Supplemental oxygen, a therapy that has been used for more than a century, is recommended in all practice guidelines in the management of hypoxemic (peripheral oxygen saturation <90% to 94% or partial arterial oxygen pressure <60 mm Hg) patients with acute heart failure, but its use in normoxemic patients is controversial. Several pre-clinical and early clinical studies have shown the detrimental effects of oxygen therapy and subsequent hyperoxia in patients with normal oxygen saturation levels. These effects are suggested to be gauged by the increased production of reactive oxygen species and the related oxidative stress and by the reductions in coronary blood flow and myocardial oxygen consumption resulting from hyperoxia-induced vasoconstriction in the cerebral, coronary, and systemic vasculature. Considering these findings, recent practice guidelines are diverging from the previous consensus that oxygen should be administered routinely in patients with cardiac disease, but this new direction is also based on expert opinions rather than evidence such as well-designed trials. In this review, the authors summarize current evidence regarding the cardiovascular effects of supplemental oxygen therapy, particularly evidence from the field of acute heart failure, and delineate knowledge gaps in the field and future directions in research.
Article
Full-text available
Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow limitation and loss of lung function, and is currently the third largest cause of death in the world. It is now well established that cardiovascular-related comorbidities such as stroke contribute to morbidity and mortality in COPD. The mechanisms linking COPD and stroke remain to be fully defined but are likely to be interconnected. The association between COPD and stroke may be largely dependent on shared risk factors such as aging and smoking, or the association of COPD with traditional stroke risk factors. In addition, we propose that COPD-related systemic inflammation and oxidative stress may play important roles by promoting cerebral vascular dysfunction and platelet hyperactivity. In this review, we briefly discuss the pathogenesis of COPD, acute exacerbations of COPD (AECOPD) and cardiovascular comorbidities associated with COPD, in particular stroke. We also highlight and discuss the potential mechanisms underpinning the link between COPD and stroke, with a particular focus on the roles of systemic inflammation and oxidative stress.
Article
Full-text available
Background: Inconsistent results have been reported for hyperbaric oxygen therapy (HBO) for acute stroke. We conducted a systematic review and meta-analysis to evaluate the benefit of HBO in animal studies of middle cerebral artery occlusion (MCAO). Methods: A systematic search of the literature published prior to September 2015 was performed using Embase, Medline (OvidSP), Web of Science and PubMed. Keywords included "hyperoxia" OR "hyperbaric oxygen" OR "HBO" AND "isch(a)emia" OR "focal cerebral ischemia" OR "stroke" OR "infarct" OR "middle cerebral artery occlusion (MCAO)." The primary endpoints were the infarct size and/or neurological outcome score evaluated after HBO treatment in MCAO. Heterogeneity was analyzed using Cochrane Library's RevMan 5.3.5. Results: Fifty-one studies that met the inclusion criteria were identified among the 1198 studies examined. When compared with control group data, HBO therapy resulted in infarct size reduction or improved neurological function (32% decrease in infarct size; 95% confidence interval (CI), range 28%-37%; p < 0.00001). Mortality was 18.4% in the HBO group and 26.7% in the control group (RR 0.72, 95% CI, 0.54-0.98; p = 0.03). Subgroup analysis showed that a maximal neuro-protective effect was reached when HBO was administered immediately after MCAO with an absolute atmospheric pressure (ATA) of 2.0 (50% decrease; 95% CI, 43% -57% decrease; p < 0.0001) and more than 6 hours HBO treatment (53% decrease; 95% CI, 41% -64% decrease; p = 0.0005). Conclusions: HBO had a neuro-protective effect and improved survival in animal models of MCAO, especially in animals given more than 6 hours of HBO and when given immediately after MCAO with 2.0 ATA.
Article
Full-text available
Despite state-of-the-art hyperbaric oxygen (HBO) treatment, about 30% of patients suffering neurologic decompression sickness (DCS) exhibit incomplete recovery. Since the mechanisms of neurologic DCS involve ischemic processes which result in excitotoxicity, it is likely that HBO in combination with an anti-excitotoxic treatment would improve the outcome in patients being treated for DCS. Therefore, in the present study, we investigated the effect of the noble gas xenon in an ex vivo model of neurologic DCS. Xenon has been shown to provide neuroprotection in multiple models of acute ischemic insults. Fast decompression compared to slow decompression induced an increase in lactate dehydrogenase (LDH), a well-known marker of sub-lethal cell injury. Post-decompression administration of xenon blocked the increase in LDH release induced by fast decompression. These data suggest that xenon could be an efficient additional treatment to HBO for the treatment of neurologic DCS.
Article
Full-text available
At present, the only FDA approved treatment for ischemic strokes is intravenous administration of tissue plasminogen activator within 4.5 hours of stroke onset. Owing to this brief window only a small percentage of patients receive tissue plasminogen activator. Transcranial laser therapy has been shown to be effective in animal models of acute ischemic stroke, resulting in significant improvement in neurological score and function. NEST-1 and NEST-2 clinical trials in human patients have demonstrated the safety and positive trends in efficacy of transcranial laser therapy for the treatment of ischemic stroke when initiated close to the time of stroke onset. Combining intravenous tissue plasminogen activator treatment with transcranial laser therapy may provide better functional outcomes. Statins given within 4 weeks of stroke onset improve stroke outcomes at 90 days compared to patients not given statins, and giving statins following transcranial laser therapy may provide an effective treatment for patients not able to be given tissue plasminogen activator due to time constraints. © 2015, Editorial Board of Neural Regeneration Research. All rights reserved.
Article
Treatments for acute ischaemic stroke continue to evolve after the superior value of endovascular thrombectomy was confirmed over systemic thrombolysis. Unfortunately, numerous neuroprotective drugs have failed to show benefit in the treatment of acute ischaemic stroke, making the search for new treatments imperative. Increased awareness of the relevance of rigorous preclinical testing, and appropriate selection of study participants, might overcome the barriers to progress in stroke research. Relevant areas of interest include the search for safe and effective treatment strategies that combine neuroprotection reperfusion, better use of advanced brain imaging for patient selection, and wider implementation of prehospital conducted clinical trials. Randomised controlled trials of combination treatments completed within the past 5 years have included growth factors, hypothermia, minocycline, natalizumab, fingolimod, and uric acid; the latter two drugs with alteplase produced encouraging results. Blocking of excitotoxicity is also being reassessed in clinical trials with new approaches, such as the postsynaptic density-95 inhibitor NA-1, or peritoneal dialysis to remove excess glutamate. The findings of these randomised trials are anticipated to improve treatment options and clinical outcomes in of patients with acute stroke.
Article
Oxygen tension is an important factor controlling stem cell proliferation and maintenance in various stem cell populations with a particular relevance in midbrain dopaminergic progenitors. Further studies have shown that the oxygen-dependent transcription factor hypoxia-inducible factor 1ɑ (HIF-1ɑ) is involved in these processes. However, all available studies on oxygen effects in dopaminergic neuroprogenitors were performed in vitro and thus it remains unclear whether tissue oxygen tension in the embryonic midbrain is also relevant for the regulation of dopaminergic neurogenesis in vivo. We thus dissect here the effects of oxygen tension in combination with hypoxia-inducible factor HIF-1α conditional knock-out on dopaminergic neurogenesis by using a novel experimental design allowing for the control of oxygen tension within the microenvironment of the neurogenic niche of the murine fetal midbrain in vivo. The microenvironment of the midbrain dopaminergic neurogenic niche was detected as hypoxic with oxygen tensions below 1.1%. Maternal oxygen treatment of 10%, 21% and 75% atmospheric oxygen tension for 48h translates into robust changes in fetal midbrain oxygenation. Fetal midbrain hypoxia hampered the generation of dopaminergic neurons and is accompanied with restricted fetal midbrain development. Contrary, induced hyperoxia stimulated proliferation and differentiation of dopaminergic progenitors during early and late embryogenesis. Oxygen effects were not directly mediated through HIF-1α signaling. These data - in agreement with in vitro data - indicate that oxygen is a crucial regulator of developmental dopaminergic neurogenesis. Our study provides the initial framework for future studies on molecular mechanisms mediating oxygen regulation of dopaminergic neurogenesis within the fetal midbrain as its natural environment.
Article
Background: Current in vivo methods cannot distinguish between the roles of vascular and stationary tissular gas bubbles in the mechanisms of decompression sickness (DCS). New method: To answer this question, we designed a normobaric-hyperbaric chamber for studying specifically the contribution of stationary tissular gas bubbles in the mechanisms of DCS in individually-superfused tissue samples. For validating our method, we investigated in rat brain slices exposed to 0.4MPa air absolute pressure whether fast decompression rate - the most important cause of cerebral DCS - may induce an increase of lactate dehydrogenase (LDH), a marker of cell injury, compared to slow decompression rate. Results: We provide a technical description of our pressure chamber and show that fast decompression rate of 0.3MPamin(-1) induced a rapid and sustained increase of LDH release compared to slow compression rate of 0.01MPamin(-1) (P<0.0001). Comparison with existing methods: There is no current method for studying stationary tissular gas bubbles. Conclusions: This report describes the first method for studying specifically in tissue samples the role of stationary tissular gas bubbles in the mechanisms of DCS. Advantageously, according to this method (i) biological markers other than LDH could be easily studied; (ii) tissue samples could be taken not only from the brain but also from any part of the animal's body known of interest in DCS research, allowing performing tissue compartment research, a major question in the physics and theory of decompression research; and (iii) histological studies could be performed from the tissue samples.